Ads

You May Also Like

Ascendis Pharma A/S Reports Full Year 2017 Financial Results

- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve ...

Loxo Oncology to Announce Second Quarter 2016 Financial Results

STAMFORD, Conn., July 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...